Vandetanib is a tyrosine kinase inhibitor used in cancer treatment, particularly for advanced or metastatic medullary thyroid cancer. It works by inhibiting multiple receptor tyrosine kinases, including VEGFR, EGFR, and RET, which play a crucial role in tumor growth and angiogenesis. Due to its complex pharmacological nature, the production of vandetanib involves sophisticated chemical processes …
-
Subscribe
Subscribed
Have a WordPress.com account? Log in now.
